As its comeback continues, NPE allocates $20 million for new acquisitions this year - but with more than $160 million on its balance sheet it is well placed to re-build portfolio
The Foxconn affiliate has joined Nokia in filing German infringement suits against automaker Daimler, recent US court documents show
Deal with licensing entity Excalibur came shortly after social media company’s billion-dollar IPO
Korean conglomerate has been using patent transactions to seal patent deals, including with NPEs
Although it is home to many big ticket patent players, Canada has lagged in encouraging SMEs to maximise the value of the rights they own; new programme designed to reverse that trend
Leader in touchscreen technology agrees settlement with Motorola; a swollen cost base, though, is prompting activist investors to push for change
So far this year Alan Albright of the Western District of Texas is the sixth busiest in terms of the number of new case assignments; the top five is dominated by Delaware-based justices
Executives from Qualcomm and InterDigital explained some of the effects US-China tensions are having on their businesses in earnings calls this week. Huawei also gave an update
Munich court hands down unprecedented order preventing the auto supplier from applying for a US anti-suit injunction that would stymy the Finnish company's litigation in Germany
The Lone Star ruling squarely puts entities that try to monetise their IP by transferring it to third-parties at risk of being joined in any subsequent litigation
Analysis by AST shows Qualcomm, Samsung and TSMC all active, and volumes in line with recent quarterly averages; software still the leading sector in terms of number of transactions
Shenzhen-based Goodix supplies more fingerprint sensors to more phones than any other company. But it is now litigating with two of its biggest rivals in Chinese courts
Parent company Altaba has announced dissolution plan, but Excalibur IP looks set to continue monetising stockpile of grants
Acquirer not named, but Apple looks like a strong candidate to purchase the portfolio of 8,500 largely unencumbered wireless assets that was due to be auctioned in August
Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month
